Author name: Leonardo Arias

The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for growth.

The coverage landscape for the privatized Medicare plans will look significantly different next year, giving smaller players a chance to snap up market share but likely creating confusion for seniors.

Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments.

“We’ve worked hard, but have not made as much progress as is needed,” CFO Daniel Morissette said about the company’s 2025 financial results.

In this episode presented by PII, BioSpace’s head of insights discusses with guests Oliver Eden and Travis Webb how autoinjectors offer opportunities to improve delivery systems, patient compliance and clinical trial processes.

Looking for a biopharma job in Boston? Check out the BioSpace list of six companies hiring life sciences professionals like you.

The clearance gives Distalmotion, which sees opportunity in ambulatory settings, a third robotic procedure category in the U.S. Elsewhere, AiM Medical Robotics raised $8.1 million.

Both Halozyme and Elektrofi have partnered with several Big Pharma companies to provide drug delivery technologies.

El ritmo de acumulación de masa de un agujero negro lejano tiene desconcertada a la comunidad científica porque parece contradecir leyes de la física. Este hallazgo, realizado por el Observatorio espacial Chandra de rayos X de la NASA, podría aportar pistas que ayuden a d …

Los vehículos autónomos, aquellos que no necesitan de conductor y en los que todos los ocupantes son meros pasajeros, empiezan a estar más cerca de ser una realidad que podamos ver de manera cotidiana en nuestras carreteras. De ellos se dice que, gracias a su tecnología, …